We envision future NEK4 inhibitors to be used in combination with DNA-damaging agents to enhance toxicity to cancer cells for improving patient outcomes, but further exploring why some cancers’ growth is potentiated by NEK4 knockdown is critical for proper patient stratification. The gene discussed is NEK4; the disease is cancer.